XBiotech (XBIT) stock

Market cap $56.4MShares as of Aug 13

$1.85

-4.15%

As of Monday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score XBIT. It is too thinly traded for a fair Quality Score.

Healthcare · Biotech

Cash$110M, about 10 quarters (2.5 years) at the last year's spendingOn Jun 30

Follow XBIT's trial news. Pro members can get an alert when XBiotech files news, and see its trials, share raises, and its CEO's filings.

Get an alert when XBIT files news on its trialsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,191 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$110M, about 10 quarters (2.5 years) at the last year's spendingOn Jun 30

What's next for XBIT, and how long its cash lasts

Its trials

A trial underway: Natrunix in Combination With Methotrexate for Rheumatoid Arthritis TreatmentPhase 2 · Not yet recruiting · 108 people · main data estimated Jan 15, 2027 · NCT06590090

1 more trial, 11 filings, for Pro members.

Cash runway Jun 30 balance sheet

About 10 quarters

$110M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: the amounts, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

Get an alert when John Simard buys or sells

For Pro members: every trade, and John Simard’s 2 filings and quotes.

Get an alert when XBIT files news on its trialsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 15 daysANDA decisionIn 15 days · ANDA decisionNRXPNRX PharmaceuticalsPreservative-free ketamineNRXPNRX Pharmaceuticals · $104MPreservative-free ketamineA generic, under FDA review (GDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $356MDeramiocelFDA decision due (PDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $933MMolgramostimFDA decision due (PDUFA)

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 168 dates, ranked →

XBIT's latest filings

XBiotech Announces Election of Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers8-K, filed Oct 26
Quarterly report10-Q, filed Aug 13
4 insider filingsForm 4, filed Nov 12

4 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why XBIT isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. XBIT trades about 68,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.